PubMed

Lessons learned from PEPFAR.

Dybul M.

J Acquir Immune Defic Syndr. 2009 Nov;52 Suppl 1:S12-3.PMID: 19858928 [PubMed - in process]Related articles

Venice Statement on global health initiatives and health systems.

Atun R, Dybul M, Evans T, Kim JY, Moatti JP, Nishtar S, Russell A.

Lancet. 2009 Sep 5;374(9692):783-4. No abstract available. PMID: 19733777 [PubMed - indexed for MEDLINE]Related articles

An assessment of interactions between global health initiatives and country health systems.

World Health Organization Maximizing Positive Synergies Collaborative Group, Samb B, Evans T, Dybul M, Atun R, Moatti JP, Nishtar S, Wright A, Celletti F, Hsu J, Kim JY, Brugha R, Russell A, Etienne C.

Lancet. 2009 Jun 20;373(9681):2137-69.PMID: 19541040 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy.

Nies-Kraske E, Schacker TW, Condoluci D, Orenstein J, Brenchley J, Fox C, Daucher M, Dewar R, Urban E, Hill B, Guenaga J, Hoover S, Maldarelli F, Hallahan CW, Horn J, Kottilil S, Chun TW, Folino M, Palmer S, Wiegand A, O'Shea MA, Metcalf JA, Douek DC, Coffin J, Haase A, Fauci AS, Dybul M.

J Infect Dis. 2009 Jun 1;199(11):1648-56.PMID: 19432547 [PubMed - indexed for MEDLINE]Related articles

Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.

Reynolds SJ, Kityo C, Mbamanya F, Dewar R, Ssali F, Quinn TC, Mugyenyi P, Dybul M.

Antivir Ther. 2009;14(2):293-7.PMID: 19430104 [PubMed - indexed for MEDLINE]Related articlesFree article

AIDS: lessons learnt and myths dispelled.

Piot P, Kazatchkine M, Dybul M, Lob-Levyt J.

Lancet. 2009 Jul 18;374(9685):260-3. Epub 2009 Mar 19. Review. No abstract available. Erratum in: Lancet. 2009 Aug 22;374(9690):608. PMID: 19303630 [PubMed - indexed for MEDLINE]Related articles

Partnerships for blood safety in Africa: the U.S. President's Emergency Plan for AIDS Relief.

Dybul M.

Transfusion. 2008 Jun;48(6):1044-6. No abstract available. PMID: 18713107 [PubMed - indexed for MEDLINE]Related articles

Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.

Daucher M, Price DA, Brenchley JM, Lamoreaux L, Metcalf JA, Rehm C, Nies-Kraske E, Urban E, Yoder C, Rock D, Gumkowski J, Betts MR, Dybul MR, Douek DC.

J Virol. 2008 Apr;82(8):4102-14. Epub 2008 Jan 30.PMID: 18234797 [PubMed - indexed for MEDLINE]Related articlesFree article

Rapid expansion of the health workforce in response to the HIV epidemic.

Samb B, Celletti F, Holloway J, Van Damme W, De Cock KM, Dybul M.

N Engl J Med. 2007 Dec 13;357(24):2510-4. No abstract available. PMID: 18077816 [PubMed - indexed for MEDLINE]Related articles

Neglected tropical diseases and HIV/AIDS.

Dybul M.

Lancet. 2006 Nov 25;368(9550):1865. No abstract available. PMID: 17126707 [PubMed - indexed for MEDLINE]Related articles

Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection.

Powers AE, Marden SF, McConnell R, Leidy NK, Campbell CM, Soeken KL, Barker C, Davey RT, Dybul MR.

AIDS. 2006 Apr 4;20(6):837-45.PMID: 16549967 [PubMed - indexed for MEDLINE]Related articles

Developing an evidence-based, preventive care package for persons with HIV in Africa.

Mermin J, Bunnell R, Lule J, Opio A, Gibbons A, Dybul M, Kaplan J.

Trop Med Int Health. 2005 Oct;10(10):961-70.PMID: 16185230 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS.

J Exp Med. 2004 Oct 4;200(7):587-99. Erratum in: J Exp Med. 2004 Oct 4;200(7): following 946. PMID: 15508184 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS.

J Exp Med. 2004 Sep 6;200(5):587-99. Corrected and republished in: J Exp Med. 2004 Oct 4;200(7):587-99. PMID: 15353552 [PubMed - indexed for MEDLINE]Related articlesFree article

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection.

Dybul M, Nies-Kraske E, Dewar R, Maldarelli F, Hallahan CW, Daucher M, Piscitelli SC, Ehler L, Weigand A, Palmer S, Metcalf JA, Davey RT, Rock Kress DM, Powers A, Beck I, Frenkel L, Baseler M, Coffin J, Fauci AS.

J Infect Dis. 2004 Jun 1;189(11):1974-82. Epub 2004 May 10.PMID: 15143462 [PubMed - indexed for MEDLINE]Related articles

Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.

Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, Kwok WW, Migueles SA, Laborico AC, Shupert WL, Hallahan CW, Davey RT Jr, Dybul M, Vogel S, Metcalf J, Connors M.

J Virol. 2003 Oct;77(20):10900-9.PMID: 14512540 [PubMed - indexed for MEDLINE]Related articlesFree article

Selected topics from the 10th Conference on Retroviruses and Opportunistic Infections.

Dybul M.

HIV Clin Trials. 2003 Jul-Aug;4(4):282-6. No abstract available. PMID: 12916014 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters.

Dybul M, Nies-Kraske E, Daucher M, Hertogs K, Hallahan CW, Csako G, Yoder C, Ehler L, Sklar PA, Belson M, Hidalgo B, Metcalf JA, Davey RT, Rock Kress DM, Powers A, Fauci AS.

J Infect Dis. 2003 Aug 1;188(3):388-96. Epub 2003 Jul 10.PMID: 12870120 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.PMID: 12617573 [PubMed - indexed for MEDLINE]Related articles

Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.

Dybul M, Daucher M, Jensen MA, Hallahan CW, Chun TW, Belson M, Hidalgo B, Nickle DC, Yoder C, Metcalf JA, Davey RT, Ehler L, Kress-Rock D, Nies-Kraske E, Liu S, Mullins JI, Fauci AS.

J Virol. 2003 Mar;77(5):3229-37.PMID: 12584346 [PubMed - indexed for MEDLINE]Related articlesFree article

Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma.

Malaspina A, Moir S, Nickle DC, Donoghue ET, Ogwaro KM, Ehler LA, Liu S, Mican JA, Dybul M, Chun TW, Mullins JI, Fauci AS.

J Virol. 2002 Sep;76(17):8855-63.PMID: 12163605 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings.

Dybul M, Bolan R, Condoluci D, Cox-Iyamu R, Redfield R, Hallahan CW, Folino M, Sathasivam K, Weisberg M, Andrews M, Hidalgo B, Vasquez J, Fauci AS.

J Infect Dis. 2002 Jun 15;185(12):1818-21. Epub 2002 May 31.PMID: 12085332 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.PMID: 12027060 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV preferentially infects HIV-specific CD4+ T cells.

Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, Casazza JP, Kuruppu J, Kunstman K, Wolinsky S, Grossman Z, Dybul M, Oxenius A, Price DA, Connors M, Koup RA.

Nature. 2002 May 2;417(6884):95-8.PMID: 11986671 [PubMed - indexed for MEDLINE]Related articles

Structured Treatment Interruption: Approaches and Risks.

Dybul M.

Curr Infect Dis Rep. 2002 Apr;4(2):175-180.PMID: 11927050 [PubMed - as supplied by publisher]Related articles

Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection.

Dybul M, Hidalgo B, Chun TW, Belson M, Migueles SA, Justement JS, Herpin B, Perry C, Hallahan CW, Davey RT, Metcalf JA, Connors M, Fauci AS.

J Infect Dis. 2002 Jan 1;185(1):61-8. Epub 2001 Dec 14.PMID: 11756982 [PubMed - indexed for MEDLINE]Related articles

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.

Dybul M, Chun TW, Yoder C, Hidalgo B, Belson M, Hertogs K, Larder B, Dewar RL, Fox CH, Hallahan CW, Justement JS, Migueles SA, Metcalf JA, Davey RT, Daucher M, Pandya P, Baseler M, Ward DJ, Fauci AS.

Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15161-6. Epub 2001 Dec 4.PMID: 11734634 [PubMed - indexed for MEDLINE]Related articlesFree article

Approaches to interrupting HAART for the treatment of HIV infection. IAPAC sessions 2001, July 18-19, 2001 - Chicago.

Dybul M; National Institute of Allergy and Infectious Disease, US National Institutes of Health, USA.

IAPAC Mon. 2001 Aug;7(8):232-4. No abstract available. PMID: 11708275 [PubMed - indexed for MEDLINE]Related articles

Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.

Chun TW, Justement JS, Moir S, Hallahan CW, Ehler LA, Liu S, McLaughlin M, Dybul M, Mican JM, Fauci AS.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):253-8.PMID: 11136258 [PubMed - indexed for MEDLINE]Related articlesFree article

CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.

Dybul M, Mercier G, Belson M, Hallahan CW, Liu S, Perry C, Herpin B, Ehler L, Davey RT, Metcalf JA, Mican JM, Seder RA, Fauci AS.

J Immunol. 2000 Aug 1;165(3):1685-91.PMID: 10903780 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy.

Dybul M, Chun TW, Ward DJ, Hertogs K, Larder B, Fox CH, Orenstein JM, Baird BF, Li Y, Green LG, Engel D, Liu S, Mican JM, Fauci AS.

J Infect Dis. 2000 Apr;181(4):1273-9.PMID: 10836864 [PubMed - indexed for MEDLINE]Related articles

Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo.

Weissman D, Dybul M, Daucher MB, Davey RT Jr, Walker RE, Kovacs JA.

J Infect Dis. 2000 Mar;181(3):933-8.PMID: 10720515 [PubMed - indexed for MEDLINE]Related articles

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.

Chun TW, Engel D, Mizell SB, Hallahan CW, Fischette M, Park S, Davey RT Jr, Dybul M, Kovacs JA, Metcalf JA, Mican JM, Berrey MM, Corey L, Lane HC, Fauci AS.

Nat Med. 1999 Jun;5(6):651-5.PMID: 10371503 [PubMed - indexed for MEDLINE]Related articles

Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.

McDyer JF, Dybul M, Goletz TJ, Kinter AL, Thomas EK, Berzofsky JA, Fauci AS, Seder RA.

J Immunol. 1999 Mar 15;162(6):3711-7.PMID: 10092834 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of dendritic cells in the infection of CD4+ T cells with the human immunodeficiency virus: use of dendritic cells from individuals homozygous for the delta32CCR5 allele as a model.

Dybul M, Weissman D, Rubbert A, Machado E, Cohn M, Ehler L, O'Callahan M, Mizell S, Fauci AS.

AIDS Res Hum Retroviruses. 1998 Sep 1;14(13):1109-13.PMID: 9737582 [PubMed - indexed for MEDLINE]Related articles

Promethean thymus?

Dybul M, Kinter A, Ruiz M, Fauci AS.

J Clin Invest. 1998 Jun 1;101(11):2299-300. No abstract available. PMID: 9616200 [PubMed - indexed for MEDLINE]Related articlesFree article

Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry.

Rubbert A, Combadiere C, Ostrowski M, Arthos J, Dybul M, Machado E, Cohn MA, Hoxie JA, Murphy PM, Fauci AS, Weissman D.

J Immunol. 1998 Apr 15;160(8):3933-41.PMID: 9558100 [PubMed - indexed for MEDLINE]Related articlesFree article

Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.

Weissman D, Rabin RL, Arthos J, Rubbert A, Dybul M, Swofford R, Venkatesan S, Farber JM, Fauci AS.

Nature. 1997 Oct 30;389(6654):981-5.PMID: 9353123 [PubMed - indexed for MEDLINE]Related articles